# Community Bancorp: financial statements, quarterly

CMTV · Nasdaq · CIK 718413 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cmtv.md) · [Financials](/companies/cmtv/financials.md) · [Filings](/companies/cmtv/filings.md) · [Insiders](/companies/cmtv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cmtv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [3,656](/filings/0001654954-24-014367.md) | [3,844 d](/filings/0001654954-25-003447.md) | [4,502](/filings/0001654954-25-005620.md) | [5,096](/filings/0001654954-25-009542.md) | [5,306](/filings/0001654954-25-013041.md) | [5,466 d](/filings/0001654954-26-002870.md) | [5,086](/filings/0001654954-26-004950.md) | [4,956](/filings/0001654954-26-007611.md) | [4,906](/filings/0001654954-25-013041.md) | [5,058 d](/filings/0001654954-26-002870.md) | [5,079](/filings/0001654954-26-004950.md) | [4,795](/filings/0001654954-26-007611.md) |
| Income tax | $k | [724](/filings/0001654954-24-014367.md) | [628 d](/filings/0001654954-25-003447.md) | [555](/filings/0001654954-25-005620.md) | [542](/filings/0001654954-25-009542.md) | [585](/filings/0001654954-25-013041.md) | [756 d](/filings/0001654954-26-002870.md) | [663](/filings/0001654954-26-004950.md) | [819](/filings/0001654954-26-007611.md) | [1,007](/filings/0001654954-25-013041.md) | [948 d](/filings/0001654954-26-002870.md) | [875](/filings/0001654954-26-004950.md) | [987](/filings/0001654954-26-007611.md) |
| Net income | $k | [3,363](/filings/0001654954-24-014367.md) | [3,534 d](/filings/0001654954-25-003447.md) | [2,823](/filings/0001654954-25-013041.md) | [2,728](/filings/0001654954-25-013041.md) | [3,114](/filings/0001654954-25-013041.md) | [4,099 d](/filings/0001654954-26-002870.md) | [3,525](/filings/0001654954-26-007611.md) | [4,060](/filings/0001654954-26-007611.md) | [4,747](/filings/0001654954-25-013041.md) | [4,636 d](/filings/0001654954-26-002870.md) | [4,369](/filings/0001654954-26-007611.md) | [4,688](/filings/0001654954-26-007611.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.51](/filings/0001654954-25-005620.md) | [0.49](/filings/0001654954-25-009542.md) | [0.55](/filings/0001654954-25-013041.md) | not reported | [0.62](/filings/0001654954-26-004950.md) | [0.72](/filings/0001654954-26-007611.md) | [0.84](/filings/0001654954-25-013041.md) | not reported | [0.78](/filings/0001654954-26-004950.md) | [0.84](/filings/0001654954-26-007611.md) |
| Basic EPS | $ per share | [0.61](/filings/0001654954-24-014367.md) | not reported | [0.51](/filings/0001654954-25-005620.md) | [0.49](/filings/0001654954-25-009542.md) | [0.55](/filings/0001654954-25-013041.md) | not reported | [0.62](/filings/0001654954-26-004950.md) | [0.72](/filings/0001654954-26-007611.md) | [0.84](/filings/0001654954-25-013041.md) | not reported | [0.78](/filings/0001654954-26-004950.md) | [0.84](/filings/0001654954-26-007611.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [17.5](/filings/0001654954-23-014153.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,083](/filings/0001654954-23-014153.md) | [1,099](/filings/0001654954-25-003447.md) | [1,107](/filings/0001654954-24-006315.md) | [1,100](/filings/0001654954-24-010530.md) | [1,177](/filings/0001654954-24-014367.md) | [1,249](/filings/0001654954-26-002870.md) | [1,188](/filings/0001654954-25-005620.md) | [1,167](/filings/0001654954-25-009542.md) | [1,226](/filings/0001654954-25-013041.md) | [1,288](/filings/0001654954-26-007611.md) | [1,235](/filings/0001654954-26-004950.md) | [1,173](/filings/0001654954-26-007611.md) |
| Total liabilities | $m | [1,004](/filings/0001654954-23-014153.md) | [1,010](/filings/0001654954-25-003447.md) | [1,018](/filings/0001654954-24-006315.md) | [1,009](/filings/0001654954-24-010530.md) | [1,079](/filings/0001654954-24-014367.md) | [1,151](/filings/0001654954-26-002870.md) | [1,085](/filings/0001654954-25-005620.md) | [1,060](/filings/0001654954-25-009542.md) | [1,114](/filings/0001654954-25-013041.md) | [1,174](/filings/0001654954-26-007611.md) | [1,118](/filings/0001654954-26-004950.md) | [1,052](/filings/0001654954-26-007611.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [78.8](/filings/0001654954-24-014367.md) | [89.0](/filings/0001654954-26-002870.md) | [89.4](/filings/0001654954-25-013041.md) | [91.3](/filings/0001654954-25-013041.md) | [98.3](/filings/0001654954-25-013041.md) | [98.0](/filings/0001654954-26-007611.md) | [103](/filings/0001654954-26-007611.md) | [106](/filings/0001654954-26-007611.md) | [112](/filings/0001654954-25-013041.md) | [114](/filings/0001654954-26-007611.md) | [117](/filings/0001654954-26-007611.md) | [121](/filings/0001654954-26-007611.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [4,954 d](/filings/0001654954-24-014367.md) | [4,301 d](/filings/0001654954-25-003447.md) | [1,695](/filings/0001654954-25-005620.md) | [4,537 d](/filings/0001654954-25-009542.md) | [4,643 d](/filings/0001654954-25-013041.md) | [4,893 d](/filings/0001654954-26-002870.md) | [383](/filings/0001654954-26-004950.md) | [4,210 d](/filings/0001654954-26-007611.md) | [5,765 d](/filings/0001654954-25-013041.md) | [5,692 d](/filings/0001654954-26-002870.md) | [4,056](/filings/0001654954-26-004950.md) | [5,308 d](/filings/0001654954-26-007611.md) |
| Capital expenditure | $k | [262 d](/filings/0001654954-24-014367.md) | [117 d](/filings/0001654954-25-003447.md) | [293](/filings/0001654954-25-005620.md) | [431 d](/filings/0001654954-25-009542.md) | [141 d](/filings/0001654954-25-013041.md) | [(72.6) d](/filings/0001654954-26-002870.md) | [275](/filings/0001654954-26-004950.md) | [112 d](/filings/0001654954-26-007611.md) | [820 d](/filings/0001654954-25-013041.md) | [(426) d](/filings/0001654954-26-002870.md) | [160](/filings/0001654954-26-004950.md) | [494 d](/filings/0001654954-26-007611.md) |
| Dividends paid | $k | [936 d](/filings/0001654954-24-014367.md) | [904 d](/filings/0001654954-25-003447.md) | [906](/filings/0001654954-25-005620.md) | [919 d](/filings/0001654954-25-009542.md) | [920 d](/filings/0001654954-25-013041.md) | [967 d](/filings/0001654954-26-002870.md) | [973](/filings/0001654954-26-004950.md) | [985 d](/filings/0001654954-26-007611.md) | [984 d](/filings/0001654954-25-013041.md) | [1,024 d](/filings/0001654954-26-002870.md) | [1,020](/filings/0001654954-26-004950.md) | [1,030 d](/filings/0001654954-26-007611.md) |
| Share repurchases | $k | not reported | not reported | [0.0](/filings/0001654954-25-005620.md) | not reported | not reported | not reported | [35.4](/filings/0001654954-25-005620.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,522](/filings/0001654954-25-005620.md) | [5,542](/filings/0001654954-25-009542.md) | [5,564](/filings/0001654954-25-013041.md) | [5,605](/filings/0001654954-26-004950.md) | [5,613](/filings/0001654954-26-007611.md) | [5,607](/filings/0001654954-25-013041.md) | [5,586](/filings/0001654954-26-004950.md) | [5,595](/filings/0001654954-26-007611.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,600,902 at 2026-08-03, from the cover of the [10-Q filed 2026-08-14](/filings/0001654954-26-007611.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.